FAS fined Bayer for improper advertising

FAS fined Bayer for improper advertising

The manufacturer has guaranteed the positive effect and effectiveness of the medicine in eliminating joint pain.

The FAS Russia imposed an administrative fine of 200 thousand rubles on Bayer JSC for improper advertising of the medicine Teraflex Hondrokrem Forte. Video commercial was distributed on the air of the TV channel “TV-3 Russia” in December 2020.

In April, the Commission of the FAS Russia recognized that the producer guaranteed the medicine use safety, effectiveness and absence of side effects in the advertising video of the medicine “Teraflex Hondrokrem Forte”, thereby violating the requirements of the Law on Advertising.

For Reference:

In accordance with the registration certificate (LP-000276 of 17.02.2011), the medicine “Teraflex Chondrocrem Forte” is registered as a medicinal product.
In accordance with paragraph 8 of part 1 of Article 24 of the Law on Advertising-advertising of medicines should not guarantee the positive effect of the advertised object, its safety, effectiveness and the absence of side effects.
In accordance with part 6 of Article 38 of the Law on Advertising, the advertiser is responsible for violating the requirements of the legislation of the Russian Federation on advertising, stipulated by part 1 of Article 24 of the Law on Advertising.

Text  |  Info: Enter some content to the textarea in the Text element, please.

Search engine for pharmaceutical industry resources

Type in a search phrase such as - gmp and get the search result

Don’t miss your daily PharmaProm.Ru news.
SUBSCRIBE free here

SUBSCRIBE
Loading…